-
公开(公告)号:US20150337004A1
公开(公告)日:2015-11-26
申请号:US14758309
申请日:2013-12-26
发明人: Bandi PARTHASARADHI REDDY , Kura RATHNAKAR REDDY , Lanka VL SUBRAHMANYAM , Gazula Levi DAVID KRUPADANAM , Mukkera VENKATI , Neela SUDHAKAR , Kallem SRINIVAS REDDY
IPC分类号: C07J53/00
CPC分类号: C07J53/002 , C07J63/008
摘要: The invention relates to novel betulinic acid derivatives and related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
摘要翻译: 本发明涉及新颖的桦木酸衍生物和相关化合物,以及可用于治疗病毒性疾病,特别是HIV介导的疾病的药物组合物。
-
公开(公告)号:US20150291574A1
公开(公告)日:2015-10-15
申请号:US14589575
申请日:2013-07-08
申请人: Bandi PARTHASARADHI REDDY , Kura RATHNAKAR REDDY , Dasari MURALIDHARA REDDY , Matta RAMAKRISHNA REDDY , HETERO RESEARCH FOUNDATION
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Dasari Muralidhara Reddy , Matta Ramakrishna Reddy , Bandi Vamsi Krishna
IPC分类号: C07D413/14
CPC分类号: C07D413/14 , C07B2200/13
摘要: The present invention provides a novel crystalline Form of azilsartan acid, process for its preparation and pharmaceutical compositions comprising it. The present invention also provides a novel crystalline Form of azilsartan medoxomil potassium, process for its preparation and pharmaceutical compositions comprising it.
摘要翻译: 本发明提供了一种新型的唑来硫酸结晶形式,其制备方法和包含它的药物组合物。 本发明还提供了一种新型的吖唑烷酮莫昔米尔钾的结晶形式,其制备方法和包含它的药物组合物。
-
公开(公告)号:US20150080420A1
公开(公告)日:2015-03-19
申请号:US14319755
申请日:2014-06-30
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Dasari Muralidhara Reddy , Kesireddy Subash Chander Reddy , Bandi Vamsi Krishna
IPC分类号: A61K31/513 , A61K31/427
CPC分类号: A61K31/513 , A61K31/427 , C07D239/10 , C07D417/12 , A61K2300/00
摘要: The present invention relates to a novel amorphous Form of lopinavir and ritonavir mixture in the ratio of 3.8:1.2 to 4.2:0.8, process for its preparation and pharmaceutical compositions comprising it.
摘要翻译: 本发明涉及以3.8:1.2至4.2:0.8的比例的洛匹那韦和利托那韦混合物的新型无定形形式,其制备方法和包含它的药物组合物。
-
公开(公告)号:US20140200356A1
公开(公告)日:2014-07-17
申请号:US14047243
申请日:2013-10-07
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Dasari Muralidhara Reddy , Rapolu Raji Reddy , Kesireddy Subash Chander Reddy , Bandi Vamsi Krishna
IPC分类号: C07D493/04
CPC分类号: C07D493/04 , A61K9/2027 , A61K9/2054 , A61K31/34
摘要: The present invention provides novel solvated forms of darunavir and processes for their preparation. The present invention also provides novel processes for the preparation of darunavir amorphous form and pharmaceutical compositions comprising it. Thus, for example, darunavir 2-methyl-2-butanol solvate was dissolved in methylene dichloride, distilled under vacuum at 45° C. to obtain a residue, cyclohexane was added to the residue and stirred for 30 hours at 20 to 25° C., and the separated solid was filtered, washed with cyclohexane and dried under vacuum at 50° C. for 12 hours to yield darunavir amorphous form.
摘要翻译: 本发明提供了地瑞那韦的新型溶剂化形式及其制备方法。 本发明还提供了制备地瑞那韦非晶形式的新方法和包含它的药物组合物。 因此,例如,将地瑞那韦2-甲基-2-丁醇溶剂合物溶解在二氯甲烷中,在45℃下真空蒸馏,得到残留物,将环己烷加入残留物中,在20〜25℃下搅拌30小时 将分离出的固体过滤,用环己烷洗涤,在50℃下真空干燥12小时,得到地瑞那韦非晶形式。
-
公开(公告)号:US20180305398A1
公开(公告)日:2018-10-25
申请号:US15767756
申请日:2016-10-12
发明人: Parthasaradhi Reddy BANDI , Rathnakar Reddy KURA , David Krupadanam GAZULA LEVI , Panduranga Reddy ADULLA , Bhaskar Reddy KASIREDDY , Carl Thomas Wild , David Eugene Martin , Theodore John Nitz
摘要: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.
-
公开(公告)号:US20170275255A1
公开(公告)日:2017-09-28
申请号:US15508540
申请日:2015-09-02
IPC分类号: C07D231/46 , C07C201/12 , C07D231/08
CPC分类号: C07D231/46 , C07C201/12 , C07D231/08
摘要: The present invention relates to crystalline form of Eltrombopag free acid and its process for preparation.
-
公开(公告)号:US09624172B2
公开(公告)日:2017-04-18
申请号:US15119294
申请日:2015-02-13
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Dasari Muralidhara Reddy , Jambula Mukunda Reddy , Bandi Vamsi Krishna
IPC分类号: C07D211/58
CPC分类号: C07D211/58
摘要: The present invention provides novel polymorphs of Lomitapide, process for their preparation and pharmaceutical compositions comprising them. The present invention also provides a novel polymorph of Lomitapide mesylate, process for its preparation and pharmaceutical compositions comprising it.
-
公开(公告)号:US20170007537A1
公开(公告)日:2017-01-12
申请号:US15119439
申请日:2015-02-16
IPC分类号: A61K9/00 , A61K31/407
摘要: The present invention relates to liquid compositions of asenapine with one or more pharmaceutically acceptable excipients. More particularly, the present invention relates to liquid spray compositions comprising asenapine for administration through oral mucosa.
摘要翻译: 本发明涉及具有一种或多种药学上可接受的赋形剂的阿替那非的液体组合物。 更具体地说,本发明涉及包含用于通过口腔粘膜施用的阿萘那平的液体喷雾组合物。
-
公开(公告)号:US20160184268A1
公开(公告)日:2016-06-30
申请号:US14915714
申请日:2014-09-01
IPC分类号: A61K31/4152 , A61K9/20
CPC分类号: A61K31/4152 , A61K9/2054 , A61K9/2059 , A61K9/2077
摘要: The present invention relates to compositions of eltrombopag olamine. The present invention also relates to process for preparing compositions comprising eltrombopag olamine.
摘要翻译: 本发明涉及埃曲波帕胺的组合物。 本发明还涉及制备包含埃曲波帕胺的组合物的方法。
-
公开(公告)号:US09156789B2
公开(公告)日:2015-10-13
申请号:US14401191
申请日:2013-05-21
发明人: Bandi Parthasaradhi Reddy , Kura Rathnakar Reddy , Dasari Muralidhara Reddy , Thungathurthy Srinivasa Rao , Bandi Vamsi Krishna
IPC分类号: A61K31/44 , C07D213/63 , C07D213/81
CPC分类号: C07D213/81
摘要: The present invention provides a novel process for the preparation of sorafenib tosylate polymorph III.
摘要翻译: 本发明提供了制备索拉非尼甲苯磺酸盐多晶型III的新方法。
-
-
-
-
-
-
-
-
-